Search results for
5187 items
Equality and Human Rights Consultation - NICE TA - Sarilumab for Previously Treated Moderate to Severe Active Rheumatoid Arthritis
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Tofacitinib for treating Moderate to Severe Active Rheumatoid Arthritis after the Failure of Disease-Modifying Anti-Rheumatic Drugs
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Immunosuppressive Therapy for Kidney Transplantation in Adults (Review of TA85)
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Immunosuppressive Therapy for Kidney Transplantation in Children and Adolescents (Review of TA 99)
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Intrabeam Radiotherapy System for Adjuvant Treatment of Early Breast Cancer
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Brentuximab Vedotin for Treating Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Inotuzumab Ozogamicin for Treating Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Sorafenib for Advanced Hepatocellular Carcinoma (review of TA189)
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Cetuximab for the treatment of metastatic and/or recurrent squamous cell carcinoma of the head and neck (review of TA172)
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Dimethyl Fumarate for Treating Moderate to Severe Plaque Psoriasis
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Autologous Chondrocyte Implantation for Repairing Symptomatic Articular Cartilage Defects of the Knee (Including a Review of TA89)
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Naltrexone-Bupropion (Prolonged Release) for Managing Overweight and Obesity
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Eluxadoline for Treating Irritable Bowel Syndrome with Diarrhoea
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Reslizumab for Treating Eosinophilic Asthma
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Carfilzomib for Treated Multiple Myeloma
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Holoclar for Treating Limbal Stem Cell Deficiency after Eye Burns
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Bisphosphonates for Preventing Osteoporotic Fragility Fractures (Including a Partial Update of NICE Technology Appraisal Guidance 160 and 161)
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Cabozantinib for Previously Treated Advanced Renal Cell Carcinoma
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the
Equality and Human Rights Consultation - NICE TA - Baricitinib for Moderate to Severe Rheumatoid Arthritis
NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the